Key Takeaways
- DKNG shares declined approximately 10% on Wednesday, settling near $22.52, with trading volume down 82% from typical levels
- Legislative developments in the Senate regarding sports betting sparked investor concerns and accelerated the selloff
- NCAA initiated legal action against DraftKings to prevent use of tournament-related trademarks during critical betting season
- Earlier this year, DraftKings reduced its 2026 revenue forecast to $6.5–6.9B, falling short of analyst expectations by more than $600M
- Wall Street maintains a generally optimistic stance with a consensus price target of $37.09, representing significant upside from current valuation
DraftKings (DKNG) shares closed Wednesday’s session around $22.52, marking a substantial decline of approximately 10% for the day.
The sharp downturn stems from dual catalysts hitting simultaneously. Market participants reacted negatively to developments surrounding a Senate betting bill, while the NCAA simultaneously launched litigation aimed at preventing the sports betting giant from utilizing tournament-specific branding, including the iconic “March Madness” phrase.
The NCAA’s legal action comes at an especially inopportune moment. The lawsuit arrives during the height of tournament season — historically among the most profitable and high-traffic windows for sports wagering platforms. Potential restrictions on marketing campaigns or court-ordered limitations could significantly impact promotional strategies and near-term revenue generation.
Trading activity on Wednesday registered just north of 2.8 million shares, representing an 82% decline from the typical session average of 15.6 million. Such diminished liquidity can exaggerate price volatility in both directions.
This latest setback continues a challenging year for DKNG throughout 2026. Company leadership previously announced full-year revenue projections of $6.5–6.9 billion, a figure that missed Street consensus by over $600 million. That disclosure triggered a mid-teens percentage decline and initiated sustained downward momentum.
Revenue Forecast Reduction Follows Impressive 2025 Performance
The guidance disappointment proved particularly jarring considering the robust fourth-quarter 2025 results. Top-line revenue reached approximately $1.99 billion, representing 43% growth compared to the prior year. Full-year adjusted EBITDA surged more than threefold to around $620 million, while the company achieved positive net income for the first time in its history.
DraftKings ultimately provided the profitability milestone investors had long anticipated — only to temper future expectations shortly thereafter. This contradiction effectively reset the company’s growth trajectory entering 2026.
Shares currently trade significantly beneath both the 50-day moving average of $26.39 and the 200-day moving average of $32.01, underscoring the persistent downward pressure following the revised guidance.
From a competitive positioning perspective, DraftKings has pursued an aggressive pricing strategy. Analysis conducted during the March Madness tournament revealed DKNG offering the most favorable average vigorish among leading operators across moneyline and total wagers. While this approach sustains customer engagement, it simultaneously compresses profit margins.
Analyst Community Remains Constructive Despite Recent Target Reductions
The analyst community continues backing the stock. Current consensus shows 25 Buy ratings, five Hold recommendations, and two Sell calls. The mean 12-month price objective stands at $37.09 — representing over 60% potential appreciation from Wednesday’s closing level.
Mizuho analysts lowered their target from $46 to $44 while preserving an “outperform” designation. Stifel reduced expectations from $44 to $40, retaining a “buy” stance. Jefferies maintains a $46 price objective. Wells Fargo reiterated its “overweight” recommendation.
Regarding insider transactions, Director Harry Sloan acquired 100,000 shares at $21.85 during February — a $2.185 million commitment signaling confidence at those depressed valuations. That purchase now trades roughly at breakeven relative to current market prices.
Company insiders collectively divested approximately 549,495 shares over the trailing 90-day period, though they maintain 47.08% ownership. Institutional investors control 37.7% of outstanding shares.
The equity trades near its 52-week lows, carrying a market capitalization around $10.63 billion and exhibiting a beta coefficient of 1.67.
